| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |